Mary van den Berg-Wolf

Smoking-Related Health Risks Among Persons With HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial

Alan R. Lifson, Jacqueline Neuhaus, José Ramón Arribas et al. · American Journal of Public Health · 2010 · 280 citations

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

Rodger D. MacArthur, Richard M. Novak, Grace Peng et al. · The Lancet · 2006 · 138 citations

Protease Inhibitors, Long-term Randomised Trial, Treatment And Prevention +9

Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy

Richard M. Novak, L. Chen, Rodger D. MacArthur et al. · Clinical Infectious Diseases · 2005 · 129 citations · Full text

Ethnicity, Race, and Gender

Ellen Tedaldi, Judith Absalon, Avis J. Thomas et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 55 citations

Virologic, Immunologic, Clinical, Safety, and Resistance Outcomes from a Long-Term Comparison of Efavirenz-Based Versus Nevirapine-Based Antiretroviral Regimens as Initial Therapy in HIV-1—Infected Persons

Mary van den Berg-Wolf, Katherine Huppler Hullsiek, Grace Peng et al. · HIV Clinical Trials · 2008 · 50 citations · Full text